FTC Sues Endo, Impax, Amneal For Antitrust Pact To Monopolize Opana ER Opioids Market
WASHINGTON, D.C. — The U.S. Federal Trade Commission on Jan. 25 filed a civil antitrust complaint against Endo Pharmaceuticals Inc., Impax Laboratories LLC and Amneal Pharmaceuticals Inc., alleging that the defendants’...To view the full article, register now.
Already a subscriber? Click here to view full article